FDA/NIH dental MOU
This article was originally published in The Gray Sheet
Executive Summary
Memorandum of understanding between FDA and the National Institutes of Health's National Institute of Dental Research has as its "principal goal" the reduction of time between the research and development phase of a dental product's life cycle and its commercial availability, FDA says in a June 2 Federal Register notice. The MOU will "facilitate interactions between" NIDR and the agency regarding "improvements in the quality and relevance of pre-clinical and clinical research" on products for use in oral health care. By enhancing the quality of product-related research, the organizations will "facilitate and improve premarket evaluations"...